News Focus
News Focus
Followers 568
Posts 27175
Boards Moderated 1
Alias Born 03/18/2015

Re: None

Monday, 11/08/2021 7:48:37 PM

Monday, November 08, 2021 7:48:37 PM

Post# of 118618
Just reviewing my notes on Regen history, honestly, what Dr Santosh Kesari, Dr Harry Lander, and Dr Thomas Ichim were able to do will be remembered for all time. So far ahead of their time! The patents and multiple FDA IND clearances dont lie!! All encompassing!!! Each are massive associations! Look them up! You find names like American Cancer Association, John Hopkins, And even Cornell Dean of Research!!!

Yup. I know what I own!

Activily being reinstated FDA INDs already 6 months into reactivation, leading to a Multiple INDs in active mRNA Human Clinical Trials company. With Funding and Collaborations to choose because of impressive past associations, the undeniable science, and current mRNA craze.

Then there is the undeniable Patent protections in and all around Nr2F6. The Global NR2F6 advancing studies: which will draw Funding and Collaborations to choose from just from a point of necessity as Regen practically owns NR2F6… and can in fact provide leaps and bound advances over some current studies.

IMHO.

Sometimes its Skil, Sometimes its Luc.

I Appreciate All Member Follows!

Desperate Sellers Become Desperate Buyers. Vice Versa

ALL IMHO.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y